Refractory High Grade B-Cell Lymphoma
specificA high-grade B-cell lymphoma that is resistant to treatment.
10
Centers
7
Active Trials
—
Cancer Funding
Top Centers for Refractory High Grade B-Cell Lymphoma(10)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 75.2 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 61.8 |
| 3 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 61.8 |
| 4 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 61.8 |
| 5 | University of Illinois Cancer CenterChicago, IL Active Research Program | 61.8 |
| 6 | Cancer Center at IllinoisUrbana, IL Active Research Program | 61.8 |
| 7 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 41.5 |
| 8 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 41.5 |
| 9 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive | 41.5 |
| 10 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 41.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →